INOVIO PHARMACEUTICALS, INC. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
INOVIO PHARMACEUTICALS, INC. (INO) had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $2.70 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2026-08-12
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $2.70M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $2.30M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $1.20M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $1.60M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $2.30M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.20M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.60M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $2.00M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.90M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.10M 10-K · filed 2026-03-12 |
| 2024-09-30 | $2.80M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.70M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.30M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $4.30M 10-K · filed 2025-03-18 |
| 2023-09-30 | $5.90M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $8.70M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $10.50M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $10.50M 10-K · filed 2024-03-06 |
| 2022-09-30 | $11.40M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $15.50M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $19.80M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $16.50M 10-K · filed 2023-03-01 |
| 2021-09-30 | $18.60M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $19.80M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $22.30M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $4.40M 10-K · filed 2022-03-01 |
| 2020-09-30 | $9.70M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $9.40M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $8.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.40M 10-K · filed 2021-03-01 |
| 2019-09-30 | $4.30M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $6.00M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $7.30M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.20M 10-K · filed 2020-03-12 |
| 2018-09-30 | $6.30M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $7.70M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $8.70M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $5.90M 10-K · filed 2019-03-12 |
| 2017-09-30 | $7.50M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $8.60M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $9.50M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $5.80M 10-K · filed 2018-03-14 |
| 2016-09-30 | $6.90M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $7.80M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $8.30M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $5.40M 10-K · filed 2017-03-15 |
| 2015-09-30 | $8.20M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $7.30M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $7.90M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $5.30M 10-K · filed 2016-03-14 |
| 2014-09-30 | $5.80M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $6.70M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $6.00M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $956.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $1.20M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $1.30M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $1.40M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $944.00K 10-K · filed 2014-03-17 |
| 2012-09-30 | $1.10M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $1.30M 10-Q · filed 2012-08-09 |
| 2011-12-31 | $981.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |